株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

腱炎治療:タイプ別、治療別、エンドユーザー別の南北アメリカ・欧州市場予測

Tendinitis Treatment Market Information: By Type, By Treatment, By End User - Americas & Europe Forecast till 2023

発行 Market Research Future 商品コード 781831
出版日 ページ情報 英文 128 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.53円で換算しております。
Back to Top
腱炎治療:タイプ別、治療別、エンドユーザー別の南北アメリカ・欧州市場予測 Tendinitis Treatment Market Information: By Type, By Treatment, By End User - Americas & Europe Forecast till 2023
出版日: 2019年01月31日 ページ情報: 英文 128 Pages
概要

当レポートでは、南北アメリカおよび欧州の腱炎治療市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 レポートのプロローグ

第2章 市場イントロダクション

  • 定義
  • 調査範囲
  • 調査目的
  • 仮定と限界
  • 市場構造

第3章 調査方法

第4章 市場動向

  • イントロダクション
  • 促進因子
  • 阻害因子
  • 機会
  • メガトレンド
  • マクロ経済指標
  • 治療をしていない患者数
  • 製品の機会

第5章 市場因子予測

  • ポーターズファイブフォースモデル
  • バリューチェーン分析
  • 需要と供給:ギャップ分析
  • 価格分析
  • 投資機会分析

第6章 タイプ別市場

  • イントロダクション
  • テニス、ゴルファー肘
  • アキレス腱
  • 棘上筋腱炎
  • デケルバン腱鞘炎
  • その他

第7章 治療別市場

  • イントロダクション
  • 治療
  • 診断
  • 医療機器
  • その他

第8章 エンドユーザー別市場

  • イントロダクション
  • 病院・クリニック
  • 医療研究センター
  • 学術機関
  • その他

第9章 地域別市場

  • イントロダクション
  • 南北アメリカ
  • 欧州

第10章 企業動向

第11章 企業プロファイル

  • Abbott
  • Pfizer Inc.
  • AstraZeneca
  • Bayer
  • Merck & Co. Inc.
  • GlaxoSmithKline plc
  • Teva Pharmaceutical Industries
  • Boehringer Ingelheim
図表

List of Tables

  • TABLE 1 PRIMARY INTERVIEWS
  • TABLE 2 NUMBER OF PATIENTS NOT SEEKING TREATMENT
  • TABLE 3 AMERICAS & EUROPE TENDINITIS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 4 AMERICAS & EUROPE TENNIS OR GOLFER'S ELBOW MARKET BY REGION, 2014 TO 2023 (USD MILLION)
  • TABLE 5 AMERICAS & EUROPE ACHILLES TENDINITIS MARKET BY REGION, 2014 TO 2023 (USD MILLION)
  • TABLE 6 AMERICAS & EUROPE SUPRASPINATUS TENDINITIS MARKET BY REGION, 2014 TO 2023 (USD MILLION)
  • TABLE 7 AMERICAS & EUROPE DE QUERVAIN'S STENOSING TENOSYNOVITIS MARKET BY REGION, 2014 TO 2023 (USD MILLION)
  • TABLE 8 AMERICAS & EUROPE OTHERS MARKET BY REGION, 2014 TO 2023 (USD MILLION)
  • TABLE 9 AMERICAS & EUROPE TENDINITIS MARKET BY TREATMENT, 2014 TO 2023 (USD MILLION)
  • TABLE 10 AMERICAS & EUROPE TENDINITIS MARKET FOR THERAPY BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 11 AMERICAS & EUROPE TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 12 AMERICAS & EUROPE TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 13 AMERICAS & EUROPE TENDINITIS MARKET FOR DIAGNOSIS BY TYPES, 2014 TO 2023 (USD MILLION)
  • TABLE 14 AMERICAS & EUROPE TENDINITIS MARKET FOR IMAGING TEST BY TYPES, 2014 TO 2023 (USD MILLION)
  • TABLE 15 AMERICAS & EUROPE THERAPY MARKET BY REGION, 2014 TO 2023 (USD MILLION)
  • TABLE 16 AMERICAS & EUROPE DIAGNOSIS MARKET BY REGION, 2014 TO 2023 (USD MILLION)
  • TABLE 17 AMERICAS & EUROPE MEDICAL DEVICES MARKET BY REGION, 2014 TO 2023 (USD MILLION)
  • TABLE 18 AMERICAS & EUROPE OTHERS MARKET BY REGION, 2014 TO 2023 (USD MILLION)
  • TABLE 19 AMERICAS & EUROPE TENDINITIS MARKET BY END USER, 2014 TO 2023 (USD MILLION)
  • TABLE 20 AMERICAS & EUROPE HOSPITALS & CLINICS MARKET BY REGION, 2014 TO 2023 (USD MILLION)
  • TABLE 21 AMERICAS & EUROPE MEDICAL RESEARCH CENTERS MARKET BY REGION, 2014 TO 2023 (USD MILLION)
  • TABLE 22 AMERICAS & EUROPE ACADEMIC INSTITUTES MARKET BY REGION, 2014 TO 2023 (USD MILLION)
  • TABLE 23 AMERICAS & EUROPE OTHERS MARKET BY REGION, 2014 TO 2023 (USD MILLION)
  • TABLE 24 AMERICAS & EUROPE TENDINITIS MARKET BY REGION, 2014 TO 2023 (USD MILLION)
  • TABLE 25 AMERICAS TENDINITIS MARKET BY REGION, 2014 TO 2023 (USD MILLION)
  • TABLE 26 AMERICAS TENDINITIS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 27 AMERICAS TENDINITIS MARKET BY TREATMENT, 2014 TO 2023 (USD MILLION)
  • TABLE 28 AMERICAS TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 29 AMERICAS TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 30 AMERICAS TENDINITIS MARKET FOR THERAPY BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 31 AMERICAS TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 32 AMERICAS TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 33 AMERICAS TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 34 AMERICAS TENDINITIS MARKET BY END USER, 2014 TO 2023 (USD MILLION)
  • TABLE 35 NORTH AMERICAS TENDINITIS MARKET BY REGION, 2014 TO 2023 (USD MILLION)
  • TABLE 36 NORTH AMERICAS TENDINITIS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 37 NORTH AMERICAS TENDINITIS MARKET BY TREATMENT, 2014 TO 2023 (USD MILLION)
  • TABLE 38 NORTH AMERICAS TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 39 NORTH AMERICAS TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 40 NORTH AMERICAS TENDINITIS MARKET FOR THERAPY BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 41 NORTH AMERICAS TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 42 NORTH AMERICAS TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 43 NORTH AMERICAS TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 44 NORTH AMERICAS TENDINITIS MARKET BY END USER, 2014 TO 2023 (USD MILLION)
  • TABLE 45 U.S. TENDINITIS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 46 U.S. TENDINITIS MARKET BY TREATMENT, 2014 TO 2023 (USD MILLION)
  • TABLE 47 U.S. TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 48 U.S. TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 49 U.S. TENDINITIS MARKET FOR THERAPY BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 50 U.S. TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 51 U.S. TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 52 U.S. TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 53 U.S. TENDINITIS MARKET BY END USER, 2014 TO 2023 (USD MILLION)
  • TABLE 54 CANADA TENDINITIS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 55 CANADA TENDINITIS MARKET BY TREATMENT, 2014 TO 2023 (USD MILLION)
  • TABLE 56 CANADA TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 57 CANADA TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 58 CANADA TENDINITIS MARKET FOR THERAPY BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 59 CANADA TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 60 CANADA TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 61 CANADA TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 62 CANADA TENDINITIS MARKET BY END USER, 2014 TO 2023 (USD MILLION)
  • TABLE 63 SOUTH AMERICAS TENDINITIS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 64 SOUTH AMERICAS TENDINITIS MARKET BY TREATMENT, 2014 TO 2023 (USD MILLION)
  • TABLE 65 SOUTH AMERICAS TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 66 SOUTH AMERICAS TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 67 SOUTH AMERICAS TENDINITIS MARKET FOR THERAPY BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 68 SOUTH AMERICAS TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 69 SOUTH AMERICAS TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 70 SOUTH AMERICAS TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 71 SOUTH AMERICAS TENDINITIS MARKET BY END USER, 2014 TO 2023 (USD MILLION)
  • TABLE 72 EUROPE TENDINITIS MARKET BY REGION, 2014 TO 2023 (USD MILLION)
  • TABLE 73 EUROPE TENDINITIS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 74 EUROPE TENDINITIS MARKET BY TREATMENT, 2014 TO 2023 (USD MILLION)
  • TABLE 75 EUROPE TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 76 EUROPE TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 77 EUROPE TENDINITIS MARKET FOR THERAPY BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 78 EUROPE TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 79 EUROPE TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 80 EUROPE TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 81 EUROPE TENDINITIS MARKET BY END USER, 2014 TO 2023 (USD MILLION)
  • TABLE 82 WESTERN EUROPE TENDINITIS MARKET BY REGION, 2014 TO 2023 (USD MILLION)
  • TABLE 83 WESTERN EUROPE TENDINITIS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 84 WESTERN EUROPE TENDINITIS MARKET BY TREATMENT, 2014 TO 2023 (USD MILLION)
  • TABLE 85 WESTERN EUROPE TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 86 WESTERN EUROPE TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 87 WESTERN EUROPE TENDINITIS MARKET FOR THERAPY BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 88 WESTERN EUROPE TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 89 WESTERN EUROPE TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 90 WESTERN EUROPE TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 91 WESTERN EUROPE TENDINITIS MARKET BY END USER, 2014 TO 2023 (USD MILLION)
  • TABLE 92 GERMANY TENDINITIS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 93 GERMANY TENDINITIS MARKET BY TREATMENT, 2014 TO 2023 (USD MILLION)
  • TABLE 94 GERMANY TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 95 GERMANY TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 96 GERMANY TENDINITIS MARKET FOR THERAPY BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 97 GERMANY TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 98 GERMANY TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 99 GERMANY TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 100 GERMANY TENDINITIS MARKET BY END USER, 2014 TO 2023 (USD MILLION)
  • TABLE 101 FRANCE TENDINITIS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 102 FRANCE TENDINITIS MARKET BY TREATMENT, 2014 TO 2023 (USD MILLION)
  • TABLE 103 FRANCE TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 104 FRANCE TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 105 FRANCE TENDINITIS MARKET FOR THERAPY BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 106 FRANCE TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 107 FRANCE TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 108 FRANCE TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 109 FRANCE TENDINITIS MARKET BY END USER, 2014 TO 2023 (USD MILLION)
  • TABLE 110 U.K. TENDINITIS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 111 U.K. TENDINITIS MARKET BY TREATMENT, 2014 TO 2023 (USD MILLION)
  • TABLE 112 U.K. TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 113 U.K. TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 114 U.K. TENDINITIS MARKET FOR THERAPY BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 115 U.K. TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 116 U.K. TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 117 U.K. TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 118 U.K. TENDINITIS MARKET BY END USER, 2014 TO 2023 (USD MILLION)
  • TABLE 119 ITALY TENDINITIS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 120 ITALY TENDINITIS MARKET BY TREATMENT, 2014 TO 2023 (USD MILLION)
  • TABLE 121 ITALY TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 122 ITALY TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 123 ITALY TENDINITIS MARKET FOR THERAPY BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 124 ITALY TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 125 ITALY TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 126 ITALY TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 127 ITALY TENDINITIS MARKET BY END USER, 2014 TO 2023 (USD MILLION)
  • TABLE 128 SPAIN TENDINITIS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 129 SPAIN TENDINITIS MARKET BY TREATMENT, 2014 TO 2023 (USD MILLION)
  • TABLE 130 SPAIN TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 131 SPAIN TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 132 SPAIN TENDINITIS MARKET FOR THERAPY BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 133 SPAIN TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 134 SPAIN TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 135 SPAIN TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 136 SPAIN TENDINITIS MARKET BY END USER, 2014 TO 2023 (USD MILLION)
  • TABLE 137 REST OF WESTERN EUROPE TENDINITIS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 138 REST OF WESTERN EUROPE TENDINITIS MARKET BY TREATMENT, 2014 TO 2023 (USD MILLION)
  • TABLE 139 REST OF WESTERN EUROPE TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 140 REST OF WESTERN EUROPE TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 141 REST OF WESTERN EUROPE TENDINITIS MARKET FOR THERAPY BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 142 REST OF WESTERN EUROPE TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 143 REST OF WESTERN EUROPE TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 144 REST OF WESTERN EUROPE TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 145 REST OF WESTERN EUROPE TENDINITIS MARKET BY END USER, 2014 TO 2023 (USD MILLION)
  • TABLE 146 EASTERN EUROPE TENDINITIS MARKET BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 147 EASTERN EUROPE TENDINITIS MARKET BY TREATMENT, 2014 TO 2023 (USD MILLION)
  • TABLE 148 EASTERN EUROPE TENDINITIS MARKET FOR DIAGNOSIS BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 149 EASTERN EUROPE TENDINITIS MARKET FOR IMAGING TEST BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 150 EASTERN EUROPE TENDINITIS MARKET FOR THERAPY BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 151 EASTERN EUROPE TENDINITIS MARKET FOR NON-PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 152 EASTERN EUROPE TENDINITIS MARKET FOR PHARMACOLOGICAL BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 153 EASTERN EUROPE TENDINITIS MARKET FOR MEDICAL DEVICES BY TYPE, 2014 TO 2023 (USD MILLION)
  • TABLE 154 EASTERN EUROPE TENDINITIS MARKET BY END USER, 2014 TO 2023 (USD MILLION)

List of Figures

  • FIGURE 1 AMERICAS & EUROPE TENDINITIS MARKET, BY TYPE, 2016 (%)
  • FIGURE 2 AMERICAS & EUROPE TENDINITIS MARKET, BY TREATMENT 2016 (%)
  • FIGURE 3 AMERICAS & EUROPE TENDINITIS MARKET, BY END USER, 2016 (%)
  • FIGURE 4 AMERICAS & EUROPE TENDINITIS MARKET, BY REGION 2016 (%)
  • FIGURE 5 MARKET STRUCTURE OF AMERICAS & EUROPE TENDINITIS MARKET
  • FIGURE 6 RESEARCH METHODOLOGY
  • FIGURE 7 DRIVERS AND RESTRAINTS FOR THE TENDINITIS MARKET
  • FIGURE 8 PORTERS FIVE FORCES MODEL
  • FIGURE 9 VALUE CHAIN: TENDINITIS TREATMENT MARKET
  • FIGURE 10 AMERICAS & EUROPE TENDINITIS MARKET BY TYPE, 2016 & 2023 (USD MILLION)
  • FIGURE 11 AMERICAS & EUROPE TENDINITIS MARKET BY TREATMENT, 2016 & 2023 (USD MILLION)
  • FIGURE 12 AMERICAS & EUROPE TENDINITIS MARKET BY END USER, 2016 & 2023 (USD MILLION)
  • FIGURE 13 AMERICAS & EUROPE TENDINITIS MARKET BY REGION, 2016 (%)
  • FIGURE 14 AMERICAS AND EUROPE TENDINITIS COMPANY SHARE ANALYSIS, 2016 (%)
目次

Tendinitis Treatment Market Information: By Type (Achilles Tendinitis, Supraspinatus Tendinitis, Tennis or Golfer's Elbow, De Quervain's Tenosynovitis), By Treatment (Diagnosis, Therapy, Shock Wave Therapy or Surgery, Medical Devices, Devices), By End User (Hospitals & Clinics, Medical Research Centers, Academic Institutes) - Americas & Europe Forecast till 2023

Market analysis

Tendinitis is the swelling of the thick cords, ligament, that attache the muscles deep down the bone. The swelling happens because of sudden damage to the ligament, redundant development of diabetes, rheumatoid joint inflammation, gout, Reiter's disorder or lupus. Tendinitis is observed to be pervasive among the sportspersons and is one of the basic sport wounds in the players, particularly tennis, golf and others. Different pharmacological and non-pharmacological medications are accessible for the treatment of tendinitis. However, surgery is one of the last solutions for tendinitis. Rising prevalence of tendinitis among the geriatric population and sports injuries is expected to boost the market growth for the tendinitis market. The Americas & Europe market for tendinitis treatment is expected to reach the approx value of USD 13,099.0 million by 2023 growing at a CAGR of 7.2% during the estimated period.

Market segmentation

The Americas & Europe tendinitis treatment market is classified on the basis of its type, end user, treatment, and regional demand. On the basis of type, the market is divided into supraspinatus tendinitis, De Quervain's tenosynovitis, Achilles tendinitis, tennis or golfer's elbow, and others. On the basis of its end user, the market is sectioned into medical research centers, hospitals & clinics, academic institutes, among others. Based on its treatment, the market is segmented into therapy, diagnosis, shock wave therapy or surgery, devices, medical devices, and others.

Regional analysis

Based on its regional analysis, the market is classified into global regions including the Americas and the Europe where America is the largest market known for the tendinitis treatment.

Major players

Some of the key players in Americas & Europe Tendinitis Treatment Market are Abbott (U.S.), Boehringer Ingelheim Pharmaceuticals, Inc. (Germany), Merck & Co. Inc. (Germany), GlaxoSmithKline plc (U.S.), Pfizer (U.S.), AstraZeneca (U.K), Bayer (Germany), Teva Pharmaceutical Industries (Israel), among others.

Table of Contents

1 Report Prologue

2 Market Introduction

  • 2.1 Definition
  • 2.2 Scope of Study
  • 2.3 Research Objective
  • 2.4 Assumptions & Limitations
    • 2.4.1 Assumptions
    • 2.4.2 Limitations
  • 2.5 Market Structure

3 Research Methodology

  • 3.1 Primary Research Methodology
  • 3.2 Secondary Research Methodology
  • 3.3 Market Share Analysis
  • 3.4 Market Pricing Approach

4 Market Dynamics

  • 4.1 Introduction
  • 4.2 Drivers
    • 4.2.1 Increasing prevalence of sports injuries (weightage 35%)
    • 4.2.2 Increasing geriatric population (weightage 30%)
    • 4.2.3 Increasing prevalence of patients suffering from diabetes and rheumatoid

arthritis (weightage 35%)

  • 4.3 Restraints
    • 4.3.1 Side effects of the treatment
  • 4.4 Opportunity
  • 4.5 Mega Trends
  • 4.6 Macroeconomic Indicators
  • 4.7 Number of patients not seeking treatment
  • 4.8 Product opportunity
    • 4.8.1 Introduction
    • 4.8.2 Medical Bands
      • 4.8.2.1 Disadvantages
      • 4.8.2.2 Product Opportunity
    • 4.8.3 OTC drugs
      • 4.8.3.1 Disadvantages
      • 4.8.3.2 Product Opportunity
    • 4.8.4 Novel Treatment Options
      • 4.8.4.1 Eccentric exercises
      • 4.8.4.2 Intratissue Percutaneous Electrolysis
      • 4.8.4.3 Sclerosant Injections
      • 4.8.4.4 Extracorporeal Shock Wave Therapy
      • 4.8.4.5 Ayurvedic Treatment for Tendinitis
      • 4.8.4.6 Stem Cells

5 Market Factor Analysis

  • 5.1 Porters Five forces Model
    • 5.1.1 Bargaining power of suppliers
    • 5.1.2 Bargaining power of buyers
    • 5.1.3 Threat of new entrants
    • 5.1.4 Threat of substitutes
    • 5.1.5 Intensity of rivalry
  • 5.2 Value Chain Analysis
    • 5.2.1 R&D
    • 5.2.2 Manufacturing
    • 5.2.3 Distribution & sales
    • 5.2.4 Post-sales monitoring
  • 5.3 Demand & Supply: Gap Analysis
  • 5.4 Pricing Analysis
  • 5.5 Investment Opportunity Analysis

6 Americas & Europe Tendinitis Market, by Type

  • 6.1 Introductions
  • 6.2 Tennis or Golfer's Elbow
  • 6.3 Achilles Tendinitis
  • 6.4 Supraspinatus Tendinitis
  • 6.5 De Quervain's Stenosing Tenosynovitis
  • 6.6 Others

7 Americas & Europe Tendinitis Market, by Treatment

  • 7.1 Introductions
  • 7.2 Therapy
  • 7.3 Diagnosis
  • 7.4 Medical Devices
  • 7.5 Others

8 Americas & Europe Tendinitis Market, by End User

  • 8.1 Introductions
  • 8.2 Hospitals & Clinics
  • 8.3 Medical Research Center
  • 8.4 Academic Institute
  • 8.5 Others

9 Americas & Europe Tendinitis Market, by Region

  • 9.1 Introductions
  • 9.2 Americas
    • 9.2.1 North America
      • 9.2.1.1 U.S.
      • 9.2.1.2 Canada
    • 9.2.2 South Americas
  • 9.3 Europe
    • 9.3.1 Western Europe
      • 9.3.1.1 Germany
      • 9.3.1.2 France
      • 9.3.1.3 U.K.
      • 9.3.1.4 Italy
      • 9.3.1.5 Spain
      • 9.3.1.6 Rest of Western Europe
    • 9.3.2 Eastern Europe

10 Company Landscape

  • 10.1 Introduction
  • 10.2 Company Share Analysis
  • 10.3 Key Developments

11 Company Profiles

  • 11.1 Abbott
    • 11.1.1 Company Overview
    • 11.1.2 Financials
    • 11.1.3 Products
    • 11.1.4 Strategy
    • 11.1.5 Key Developments
  • 11.2 Pfizer Inc.
    • 11.2.1 Company Overview
    • 11.2.2 Financials
    • 11.2.3 Products
    • 11.2.4 Strategy
    • 11.2.5 Key Developments
  • 11.3 AstraZeneca
    • 11.3.1 Company Overview
    • 11.3.2 Financials
    • 11.3.3 Products
    • 11.3.4 Strategy
    • 11.3.5 Key Developments
  • 11.4 Bayer
    • 11.4.1 Company Overview
    • 11.4.2 Financials
    • 11.4.3 Products
    • 11.4.4 Strategy
    • 11.4.5 Key Developments
  • 11.5 Merck & Co. Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Financials
    • 11.5.3 Products
    • 11.5.4 Strategy
    • 11.5.5 Key Developments
  • 11.6 GlaxoSmithKline plc
    • 11.6.1 Company Overview
    • 11.6.2 Financials
    • 11.6.3 Products
    • 11.6.4 Strategy
    • 11.6.5 Key Developments
  • 11.7 Teva Pharmaceutical Industries
    • 11.7.1 Company Overview
    • 11.7.2 Financials
    • 11.7.3 Products
    • 11.7.4 Strategy
    • 11.7.5 Key Developments
  • 11.8 Boehringer Ingelheim
    • 11.8.1 Company Overview
    • 11.8.2 Financials
    • 11.8.3 Products
    • 11.8.4 Strategy
    • 11.8.5 Key Developments

12 Conclusion

  • 12.1 Key Findings
    • 12.1.1 CEO's Viewpoint
    • 12.1.2 Unmet Needs
    • 12.1.3 Key Companies to Watch
    • 12.1.4 Prediction of Pharmaceutical Industry

13 Appendix

  • 13.1 Discussion Blue Print
  • 13.2 References
Back to Top